You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2024

Litigation Details for Galderma Laboratories, L.P. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)

✉ Email this page to a colleague

« Back to Dashboard

Galderma Laboratories, L.P. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)

Docket	⤷ Sign Up	Date Filed	2019-02-19
Court	District Court, D. Delaware	Date Terminated	2020-03-12
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	Plaintiff	Referred To
Patents	10,206,939
Attorneys	Karen Elizabeth Keller
Firms	Shaw Keller LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Galderma Laboratories, L.P. v. Teva Pharmaceuticals USA, Inc.

The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .

Details for Galderma Laboratories, L.P. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2019)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2019-02-18	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,206,939 B2. (rwc) (Entered…2019 12 March 2020 1:19-cv-00351 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff	External link to document
2019-10-23	41	Opinion - Memorandum Opinion	construction of a term in U.S. Patent No. 10,206,939 ("the '939 patent"). The Court has considered…providing claim construction of a term in U.S. Patent No. 10,206,939. Within five days the parties shall submit…alleging infringement of the ' 939 patent. (D.I. 1). The patent relates to methods and compositions …quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification	External link to document
2020-03-16	99	Patent/Trademark Report to Commissioner of Patents	the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,206,939 B2. (Attachments: …2019 12 March 2020 1:19-cv-00351 835 Patent - Abbreviated New Drug Application(ANDA) Plaintiff	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.